Exciting news! ProPharma Group and The Planet Group announce merger.  Learn More >

Back to Posts

Back to Posts

December 4, 2018 Regulatory Affairs

Outsourcing Functions Doesn’t Mean You’ve Outsourced Compliance Obligations


Over the past 20 years, the traditional approach to drug development has expanded to include the outsourcing of a range of testing and manufacturing functions. As a part of their long-term strategic view, successful Sponsors understand the need to leverage the knowledge and resources that external specialist organizations bring to the table.

Sponsors of every size and type outsource clinical functions to contract research organizations (CROs) and quality system designed to keep the Sponsor and its contracted facilities compliant.

The stronger the Sponsor’s clinical quality system, the more likely their study is to be compliant with Good Clinical Practices (GCPs) and able to quickly progress to the next phase in development. This helps the Sponsor save time and money when working with their CRO to remedy something uncovered by an internal, third-party, or FDA audit.

As for Good Manufacturing Practices (GMPs), a strong quality system provides for the proper design, monitoring, and control of manufacturing processes and facilities. This ensures that drug products meet the FDA’s quality standards.

No matter how well-designed a Sponsor’s quality system is when they are outsourcing functions, it’s crucial that they have a quality agreement that extends the Sponsor’s quality system to the contracted facility.

The Necessity of a Quality Agreement

As a part of a larger outsourcing management plan, a Sponsor should have a comprehensive, written quality agreement with each of their contracted facilities. This agreement is a part of the Sponsor’s quality system and delineates what is expected of both parties by defining the obligations and responsibilities of the quality units of both parties.

Although there is no statutory or regulatory requirement for a quality agreement, regulations do require that quality unit responsibilities and procedures be in writing (21 CFR 211.22(d)). Despite the lack of a legal requirement, in their guidance on the matter, the FDA recommends that Sponsors and contractors operate under a quality agreement. Furthermore, the Agency’s guidance also states that inspectors will seek to review quality agreements during facility inspections.

Again, even though there may be a document that clearly sets out the obligations and responsibilities of the Sponsor and the contracted facility, that document does not have the power to transfer compliance obligations from the Sponsor to the contracted facility. If there is a failure in compliance on behalf of the contracted facility, the Sponsor will always be responsible.

ProPharma Group Is Your Compliance Partner

Regardless of the Sponsor’s size or their arrangement with a contracted facility, the Sponsor cannot outsource their compliance obligations. Because of this reality, they must keep their obligations in mind as they work with their contracted facilities.

ProPharma Group is your compliance partner. We work with Sponsors to create a customized quality system design that promotes GCP and GMP compliance while accommodating each Sponsor’s unique circumstances. We start by conducting a gap analysis to determine the strength of their existing quality system and submit a report that details what we found and includes recommendations based on these findings.

Based on a Sponsor’s needs, our team can build out as little or as much of the quality system as requested. When remediation is suggested, we can also help with related project management. From standard operating procedure (SOP) writing to building a quality framework to providing a solid methodology for GCP and GMP audits, our team helps Sponsors mitigate the risk of noncompliance.

Contact us today to talk to our experts about compliance and quality systems.



Your Business has Complex Challenges. ProPharma Group has Exceptional Solutions.

We partner with pharmaceutical, biotechnology, and medical device clients to tackle complex challenges. Contact us to learn how our experienced team can help ensure regulatory and development success throughout the product lifecycle.

Interested in gaining an industry edge? Let us help you stay up to date.


All fields are required.